Rhode Island

Life Science Opportunity Atlas

IP-backed formation diligence

InvestorClinical expert

Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Cip_genomics_hans
Hybridization-assisted nanopore / electronic genome mapping

Electronic genome mapping (Nabsys)—commercial Brown-origin IP with strategic exit paths.

NHGRI R43HG004433 heritage; Hitachi interest—M&A/royalty, not Slater seed.

Entity: NabsysPatents: 3Stage: commercial
US20070190542A1WO2007041621A2US20140248183A1R43HG004433
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.